RecruitingNCT07056881

Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa


Sponsor

Centre Hospitalier de Saint-Denis

Enrollment

300 participants

Start Date

Apr 11, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study looks at how well one antibiotic (monotherapy) works compared to two antibiotics (combination therapy) in treating bone infections caused by Pseudomonas aeruginosa. It includes 300 adult patients who had this type of infection confirmed by lab tests and medical imaging. The goal is to find out if using just one antibiotic is as effective as using two, while also looking at side effects, the need for more surgery, antibiotic resistance, and overall antibiotic use.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Adult patients (≥18 years old)
  • Diagnosis of osteitis or osteomyelitis due to Pseudomonas aeruginosa
  • Isolation of Pseudomonas aeruginosa from at least one deep, sterile sample (e.g., bone biopsy, joint aspiration)
  • Imaging findings consistent with osteomyelitis (MRI, CT scan, or X-ray)

Exclusion Criteria3

  • No isolation of Pseudomonas aeruginosa
  • No imaging evidence suggestive of osteomyelitis
  • Patients under 18 years of age

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Centre Hospitalier de Saint-Denis

Saint-Denis, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07056881


Related Trials